Jan Schmielau
- Immunology top 5%
- Oncology top 10%
- Molecular Biology
- Cancer Research
- Epidemiology
- Co-authors
- Olivera J. FinnWolff SchmiegelHolger KalthoffChristian RoederUlf SeifartUlrich RodeckMichael A. NalesnikMark D. Alter
- Topics
- Cancer survivorship and care (4 papers)Medical Practices and Rehabilitation (3 papers)Pancreatic and Hepatic Oncology Research (3 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- GermanyUnited States
In The Last Decade
Jan Schmielau
16 papers receiving 983 citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 674
- Oncology 435
- Molecular Biology 202
- Cancer Research 71
- Epidemiology 55
Countries citing papers authored by Jan Schmielau
This map shows the geographic impact of Jan Schmielau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Schmielau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Schmielau more than expected).
Fields of papers citing papers by Jan Schmielau
This network shows the impact of papers produced by Jan Schmielau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Schmielau. The network helps show where Jan Schmielau may publish in the future.
Co-authorship network of co-authors of Jan Schmielau
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Schmielau. A scholar is included among the top collaborators of Jan Schmielau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Schmielau. Jan Schmielau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 37 | |
| 5 | 21 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 35 | |
| 9 | Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.breakdown → | 716 |
| 10 | Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. | 53 |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 20 | |
| 14 | 6 | |
| 15 | 1 | |
| 16 | 89 |
About Jan Schmielau
Jan Schmielau is a scholar working on Physical Therapy, Sports Therapy and Rehabilitation, Oncology and Immunology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer survivorship and care (4 papers), Medical Practices and Rehabilitation (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Immunology (674 citations), Oncology (435 citations) and Cancer Research (71 citations). Jan Schmielau has collaborated with scholars based in Germany and United States. Frequent co-authors include Olivera J. Finn, Wolff Schmiegel, Holger Kalthoff, Christian Roeder, Ulf Seifart, Ulrich Rodeck, Michael A. Nalesnik, Mark D. Alter, Michael Cascio and Nehad M. Alajez. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.